H 1703

  • Massachusetts House Bill
  • 191st Legislature (2019-2020)
  • Introduced in House
  • House
  • Senate
  • Governor

An Act relative to opioid drug manufacturer assessments

Abstract

By Ms. Cronin of Easton, a petition (accompanied by bill, House, No. 1703) of Claire D. Cronin and others relative to opioid drug manufacturer assessments. Mental Health, Substance Use and Recovery.

Bill Sponsors (23)

Votes


No votes to display

Actions


Mar 09, 2020

House

Accompanied a new draft, see H4532

Sep 16, 2019

Massachusetts General Court

Hearing scheduled for 09/19/2019 from 10:00 AM-01:00 PM in B-1

Jan 22, 2019

House

Referred to the committee on Mental Health, Substance Use and Recovery

  • Referral-Committee
committee on Mental Health, Substance Use and Recovery

Senate

Senate concurred

Bill Text

Bill Text Versions Format
Bill Text PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Massachusetts General Court.

If you notice any inconsistencies with these official sources, feel free to file an issue.